[1]
Ranjan, R.K. and Chandra, A. 2018. Apalutamide: a better option for the treatment of non-metastatic castration resistant prostatic carcinoma. International Journal of Basic & Clinical Pharmacology. 7, 9 (Aug. 2018), 1853–1856. DOI:https://doi.org/10.18203/2319-2003.ijbcp20183502.